Abstract

Peritoneal dialysis inevitability results in activation of inflammatory processes and its efficiency is highly variable between patients. An improved method to isolate biomarkers and study pathophysiological mechanisms in peritoneal dialysis effluent (PDE) is expected to be of much benefit for the development of this treatment approach and help with patient management. Extracellular vesicles (EVs) are released as part of normal cellular processes. Their proteome is expected to reflect both type and health of their cell of origin. Although there is a significant interest in using EVs for “liquid biopsies”, little is reported of their presence or composition in plentiful dialysis waste fluids, including peritoneal dialysis effluent (PDE). Here we determined the presence of EVs in PDE and subsequently characterized their proteome. EVs were first isolated from PDE using differential centrifugation, then a further enrichment using size exclusion chromatography (SEC) was performed. The presence of EVs was demonstrated using transmission electron microscopy, and their particle counts were investigated using nanoparticle tracking analysis and dynamic light scattering. Using tandem mass spectrometry, marker proteins from three types of EVs i.e. apoptotic bodies, ectosomes, and exosomes were identified. The proteomic results demonstrated that the isolation of EVs by differential centrifugation helped enrich for over 2,000 proteins normally masked by abundant proteins in PDE such as albumin and SEC markedly further improved the isolation of low abundant proteins. Gene ontology analysis of all identified proteins showed the marked enrichment of exosome and membrane-associated proteins. Over 3,700 proteins were identified in total, including many proteins with known roles in peritoneal pathophysiology. This study demonstrated the prominence of EVs in PDE and their potential value as a source of biomarkers for peritoneal dialysis patients.

Highlights

  • There are two major dialysis options for end-stage renal disease i.e. peritoneal dialysis (PD) and hemodialysis

  • The overall outcome is similar between the two dialysis approaches [2], PD has been reported to have a more favorable outcome compared with hemodialysis in the first few years after starting therapy

  • As a proof of concept, here we identified and characterized Extracellular vesicles (EVs) from peritoneal dialysis effluent (PDE) of healthy PD patients using transmission electron microscopy (TEM), dynamic light scattering (DLS), and nanoparticle tracking analysis (NTA)

Read more

Summary

Introduction

There are two major dialysis options for end-stage renal disease i.e. peritoneal dialysis (PD) and hemodialysis. The overall outcome is similar between the two dialysis approaches [2], PD has been reported to have a more favorable outcome compared with hemodialysis in the first few years after starting therapy. Results vary by studies, PD appears to subsequently lose its advantage over time [3]. The reason for the less favorable outcome over time could be associated with peritoneal membrane dysfunction leading to ultrafiltration (UF) failure. Due to a wide diversity of peritoneal function between patients, both before starting and in response to PD, detailed elucidation of these pathophysiological processes would provide a better understanding of UF failure, permitting therapeutic options to be refined

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.